"DNA, Neoplasm" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
DNA present in neoplastic tissue.
| Descriptor ID |
D004273
|
| MeSH Number(s) |
D13.444.308.425
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "DNA, Neoplasm".
Below are MeSH descriptors whose meaning is more specific than "DNA, Neoplasm".
This graph shows the total number of publications written about "DNA, Neoplasm" by people in this website by year, and whether "DNA, Neoplasm" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 5 | 8 | 13 |
| 1997 | 4 | 7 | 11 |
| 1998 | 10 | 8 | 18 |
| 1999 | 5 | 2 | 7 |
| 2000 | 2 | 10 | 12 |
| 2001 | 3 | 12 | 15 |
| 2002 | 1 | 9 | 10 |
| 2003 | 4 | 11 | 15 |
| 2004 | 3 | 8 | 11 |
| 2005 | 4 | 4 | 8 |
| 2006 | 2 | 10 | 12 |
| 2007 | 1 | 8 | 9 |
| 2008 | 0 | 10 | 10 |
| 2009 | 1 | 7 | 8 |
| 2010 | 2 | 3 | 5 |
| 2011 | 2 | 4 | 6 |
| 2012 | 2 | 3 | 5 |
| 2013 | 2 | 5 | 7 |
| 2014 | 2 | 2 | 4 |
| 2015 | 6 | 2 | 8 |
| 2016 | 1 | 3 | 4 |
| 2017 | 2 | 2 | 4 |
| 2018 | 2 | 2 | 4 |
| 2019 | 3 | 2 | 5 |
| 2020 | 1 | 1 | 2 |
| 2021 | 1 | 1 | 2 |
| 2024 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "DNA, Neoplasm" by people in Profiles.
-
Silverman RF, Francis JH, Robbins MA, Dunkel IJ, Abramson DH. RB1 CIRCULATING TUMOR DNA IN THE BLOOD OF PATIENTS WITH RETINOBLASTOMA INCREASES IN UNTREATED PATIENTS. Retina. 2024 12 01; 44(12):2123-2128.
-
McConkey DJ, Singla N, Pierorazio P, Lombardo K, Matoso A, Hoffman-Censits J. Molecular subtypes of upper tract urothelial cancer: Setting the stage for precision therapy. Cancer Cell. 2021 06 14; 39(6):745-747.
-
Salib A, Mark JR. DNA analysis for prostate specimen verification: How I Do It. Can J Urol. 2021 02; 28(1):10568-10573.
-
Adamson AW, Ding YC, Mendez-Dorantes C, Bailis AM, Stark JM, Neuhausen SL. The RAD52 S346X variant reduces risk of developing breast cancer in carriers of pathogenic germline BRCA2 mutations. Mol Oncol. 2020 06; 14(6):1124-1133.
-
Miron B, Hoffman-Censits JH, Anari F, O'Neill J, Geynisman DM, Zibelman MR, Kutikov A, Viterbo R, Greenberg RE, Chen D, Lallas CD, Trabulsi EJ, Alpaugh RK, Dulaimi E, Golemis EA, Uzzo R, Ross EA, Plimack ER. Defects in DNA Repair Genes Confer Improved Long-term Survival after Cisplatin-based Neoadjuvant Chemotherapy for Muscle-invasive Bladder Cancer. Eur Urol Oncol. 2020 08; 3(4):544-547.
-
Xiao G, Lundine D, Annor GK, Canar J, Ellison V, Polotskaia A, Donabedian PL, Reiner T, Khramtsova GF, Olopade OI, Mazo A, Bargonetti J. Gain-of-Function Mutant p53 R273H Interacts with Replicating DNA and PARP1 in Breast Cancer. Cancer Res. 2020 02 01; 80(3):394-405.
-
Moreno JG, Gomella LG. Evolution of the Liquid Biopsy in Metastatic Prostate Cancer. Urology. 2019 Oct; 132:1-9.
-
Tadepalli SH, Shields CL, Shields JA, Honavar SG. Intraocular medulloepithelioma - A review of clinical features, DICER 1 mutation, and management. Indian J Ophthalmol. 2019 06; 67(6):755-762.
-
Milman T, Salomao DR, Ida CM, Capiz Correa DR, Grossniklaus HE, Zhang Q, Hamershock RA, Shields C, Shields JA, Raber I, Rapuano CJ, Patel R, Eagle RC. Conjunctival Myxoid Lesions: Clinical-Pathologic Multiparametric Analysis, Including Molecular Genetics (An American Ophthalmological Society Thesis). Am J Ophthalmol. 2019 09; 205:115-131.
-
McLaughlin J, Lally SE, Shields CL. Just another chalazion? Indian J Ophthalmol. 2019 Feb; 67(2):195.